Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
150.88
-0.84 (-0.55%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Novartis AG Revenue

Novartis AG had revenue of $14.95B in the quarter ending June 30, 2026, with 0.78% growth. This brings the company's revenue in the last twelve months to $56.69B, up 2.73% year-over-year. In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth.

Revenue (ttm)
$56.69B
Revenue Growth
+2.73%
P/S Ratio
5.06
Revenue / Employee
$753,225
Employees
75,267
Market Cap
286.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202556.67B4.95B9.57%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 201948.68B2.58B5.59%
Dec 31, 201846.10B2.70B6.21%
Dec 31, 201743.40B-6.03B-12.20%
Dec 31, 201649.44B-951.00M-1.89%
Dec 31, 201550.39B-3.25B-6.05%
Dec 31, 201453.63B918.00M1.74%
Dec 31, 201352.72B745.00M1.43%
Dec 31, 201251.97B-7.40B-12.47%
Dec 31, 201159.38B7.81B15.15%
Dec 31, 201051.56B6.46B14.32%
Dec 31, 200945.10B2.52B5.92%
Dec 31, 200842.58B3.64B9.34%
Dec 31, 200738.95B3.84B10.94%
Dec 31, 200635.11B5.35B17.99%
Dec 31, 200529.75B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson97.93B
Merck & Co.66.57B
AbbVie64.39B
Pfizer63.70B
AstraZeneca61.37B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
Revenue Rankings